Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program

Autism

Volumn 18, Issue 6, 2014, Pages 631-637

  Schubart, Jane R ^a   Camacho, Fabian ^a   Leslie, Douglas ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

autism spectrum disorder; children and adolescents; Medicaid; psychotropic medications

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; HYPNOTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT; TRANQUILIZER;

ADULT; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; MENTAL HEALTH; POLYPHARMACY; POVERTY; PRIORITY JOURNAL; TREATMENT DURATION; ADOLESCENT; CASE CONTROL STUDY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; PRESCHOOL CHILD; TIME; UNITED STATES;

ADOLESCENT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MEDICAID; POLYPHARMACY; TIME FACTORS; UNITED STATES;

EID: 84904667222     PISSN: 13623613     EISSN: 14617005     Source Type: Journal    
DOI: 10.1177/1362361313497537     Document Type: Article

References (22)

1. Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders. 2003 ; 33 (5). 527-534
2. Aman MG, Van Bourgondien ME, Wolford PL, et al. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. Journal of the American Academy of Child and Adolescent Psychiatry. 1995 ; 34 (12). 1672-1681
3. American Medical Association Hospital International Classification of Diseases, 9th Revision, Clinical Modification 2005, Chicago, American Medical Association, 2005.
4. Centers for Disease Control and Prevention (CDC) (2012). Autism and developmental disabilities monitoring (ADDM) network. Available at: http://www.cdc.gov/ncbddd/autism/addm.html (accessed 18 April 2012).
5. Ching H, Pringshei T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews. 2012 ; 5: CD009043
6. Esbensen AJ, Greenberg JS, Seltzer MM, et al. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders. 2009 ; 39 (9). 1339-1349
7. Gerhard T, Chavez B, Olfson M, et al. National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder. Journal of Clinical Psychopharmacology. 2009 ; 29 (3). 307-310
8. Gringras P. Practical paediatric psychopharmacological prescribing in autism: the potential and the pitfalls. Autism. 2000 ; 4 (3). 229-247
9. Khanna R, Jariwala K, West-Strum D. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme. Journal of Intellectual Disability Research. 2012 ;:
10. Kogan MD, Blumberg SJ, Schieve LA, et al. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics. 2009 ; 124 (5). 1395-1403
11. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine. 2002 ; 347 (5). 314-321
12. Mandell DS, Morales KH, Marcus SC, et al. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics. 2008 ; 121 (3). e441 - e448
13. Ming X, Gordon E, Kang N, et al. Use of clonidine in children with autism spectrum disorders. Brain & Development. 2008 ; 30 (7). 454-460
14. Morgan S, Taylor E. Antipsychotic drugs in children with autism. BMJ. 2007 ; 334 (7603). 1069-1070
15. Myers SM, Johnson CP. Management of children with autism spectrum disorders. Pediatrics. 2007 ; 120 (5). 1162-1182
16. Posey DJ, Stigler KA, Erickson CA, et al. Antipsychotics in the treatment of autism. Journal of Clinical Investigation. 2008 ; 118 (1). 6-14
17. Rosenberg RE, Mandell DS, Farmer JE, et al. Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. Journal of Autism and Developmental Disorders. 2010 ; 40 (3). 342-351
18. Rubin DM, Feudtner C, Localio R, et al. State variation in psychotropic medication use by foster care children with autism spectrum disorder. Pediatrics. 2009 ; 124 (2). e305 - e312
19. Scahill L. Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness. CNS Drugs. 2009 ; 23: 43-49
20. Towbin KE. Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome. Child and Adolescent Psychiatric Clinics of North America. 2003 ; 12 (1). 23-45
21. Wang L, Leslie DL. Health care expenditures for children with autism spectrum disorders in Medicaid. Journal of the American Academy of Child and Adolescent Psychiatry. 2010 ; 49 (11). 1165-1171
22. Wilens TE, Bukstein O, Brams M, et al. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/ hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2012 ; 51 (1). 74-85.e72